English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18055/20253 (89%)
Visitors : 24682254      Online Users : 493
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34673


    標題: Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma
    作者: Kuo, Yu-Hsuan
    Lai, Hong-Yue
    Chan, Ti-Chun
    Hsing, Chung-Hsi
    Huang, Steven K.
    Hsieh, Kun-Lin
    Chen, Tzu-Ju
    Li, Wan-Shan
    Lu, Jhih-Cheng
    Li, Chien-Feng
    貢獻者: Chi Mei Hospital
    Chia Nan University of Pharmacy & Science
    Chi Mei Hospital
    National Health Research Institutes - Taiwan
    Chi Mei Hospital
    Chi Mei Hospital
    Chang Jung Christian University
    Chi Mei Hospital
    Chung Hua University
    Chi Mei Hospital
    Chi Mei Hospital
    關鍵字: bladder-cancer
    comp
    progression
    biomarker
    survival
    risk
    日期: 2022
    上傳時間: 2023-12-11 14:04:18 (UTC+8)
    出版者: DOVE MEDICAL PRESS LTD
    摘要: Purpose: Cartilage oligomeric matrix protein (COMP) is known as a large pentameric glycoprotein, which interacts with various extracellular matrix proteins in tissues. COMP has been reported to play a role in multiple connective tissue disorders. Recently, elevated COMP levels have been found to be associated with increased tumor size, metastases, faster recurrence of cancer, and overall poorer survival in several cancers. However, the clinical importance of COMP in urothelial carcinoma remains unclear. We investigated the association between COMP expression and clinical outcomes in urothelial carcinoma. Patients and Methods: In this retrospective study, we collected urothelial carcinoma (UC) tissue from 340 upper urinary tract UC (UTUC) patients and 295 urinary bladder UC (UBUC) patients. Pearson???s chi-square test, Kaplan???Meier analysis, and the multivariate Cox proportional hazards model was used to examine the relationship between COMP expression and patient characteristics, pathological findings, and patient survival, such as metastasis-free survival (MFS) and disease-specific survival (DSS). Results: A total of 295 UBUC patients and 340 UTUC patients were recruited. The COMP mRNA level was significantly higher among invasive tumors (pT2???pT4) than in noninvasive tumors (pTa-T1) in UBUC groups (P < 0.01). COMP overexpression was associated with advanced T stage, nodal metastases, vascular invasion, perineural invasion, high histological grade, and high mitotic rate in both UBUC and UTUC cohorts. COMP overexpression was predictive of shorter DSS (hazard ratio [HR] in UBUC, 3.986, P < 0.001; in UTUC, 2.283, P = 0.027] and MFS (HR in UBUC, 6.813, P < 0.001; in UTUC, 4.070, P < 0.001). Kaplan???Meier analysis demonstrated high COMP expression associated with poor DSS and MFS in UTUC and UBUC groups (all P < 0.0001). Conclusion: COMP overexpression was linked to poor clinical prognosis and poor pathological features in UC. These results suggest COMP as a biomarker for UC.
    關聯: ONCOTARGETS AND THERAPY, v.15, n.CB2, pp.CC2, pp.-,
    Appears in Collections:[行政單位] 123

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML86View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback